Therapy for the acute pancreatitis;Therapie der akuten pankreatitis

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 7, 2000, Pages 571-581

  Runzi, M ^a   Layer, P ^a   Buchler, M W ^a   Beger, H G ^a   Ell, C ^a   Folsch, U R ^a   Goebell, H ^a   Hopt, U T ^a   Lankisch, P G ^a   Schmidt, W E ^a   Schmiegel, W ^a   Scholmerich, J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; CALCITONIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; DEXTRAN; GABEXATE MESILATE; GLUCAGON; IMIPENEM; MEROPENEM; METRONIDAZOLE; MEZLOCILLIN; NARCOTIC ANALGESIC AGENT; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PROCAINE; SOMATOSTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONSERVATIVE TREATMENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTENSIVE CARE; METABOLIC DISORDER; PANCREAS NECROSIS; PANCREAS PSEUDOCYST; PANCREAS SURGERY; RESPIRATORY FAILURE; ACUTE DISEASE; ACUTE HEMORRHAGIC PANCREATITIS; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; PANCREATITIS; PRACTICE GUIDELINE; PROGNOSIS;

ACUTE DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTENSIVE CARE; PANCREATITIS; PANCREATITIS, ACUTE NECROTIZING; PROGNOSIS;

EID: 0034221738     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7447     Document Type: Article

References (103)

1. Kriterien fur die Beurteilung von Konsensuskonferenzen in der Medizin
2. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines
3. Practice guidelines: A new reality in medicine. III. Impact on patient care
4. North of England evidence-based guidelines development project: Methods of guidelines development
5. Developing clinically valid practice guidelines
6. Practice guidelines in acute pancreatitis
7. Acute pancreatitis
8. The incidence and prognosis of body wall ecchymosis in acute pancreatitis
9. Amylase - Its clinical significance: A review of the literature
10. Amylase and gut infarction
11. Underestimation of acute pancreatitis: Patients with only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis
12. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis
13. Lipase/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis
14. Lipase/amylase ratio: Not helpful in the early etiological differentiation of acute pancreatitis
15. Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis
16. No parallel between the biochemical course of acute pancreatitis and morphologic findings
17. Detection of biliary origin of acute pancreatitis. Comparison of laboratory tests, ultrasound, computed tomography, and ERCP
18. Occult microlithiasis in 'idiopathic' acute pancreatitis: Prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy
19. Biliary sludge as a cause of acute pancreatitis
20. Biochemical prediction of gallstones early in an attack of acute pancreatitis
21. Correlation of serum amylase levels with pancreatic pathology and pancreatitis etiology
22. Gallstones and acute pancreatitis
23. Early detection of biliary pancreatitis
24. Gallstone migration as a cause for acute pancreatitis
25. A clinically based classification system for acute pancreatitis
26. Acute pancreatitis: Prognostic value of CT
27. Acute pancreatitis: Value of CT in establishing prognosis
28. Imaging and intervention in acute pancreatitis
29. Incremental dynamic bolus computed tomography of acute pancreatitis
30. Factors influencing morbidity and mortality in acute pancreatitis: An analysis of 279 cases
31. Comparison of multiple-parameter prognostic systems in acute pancreatitis
32. Prognostic signs and the role of operative management in acute pancreatitis
33. Etiological and prognostic factors in human acute pancreatitis: A review
34. Influence of etiology on the course and outcome of acute pancreatitis
35. Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems
36. Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994
37. No strict correlation between necrosis and organ failure in acute pancreatitis
38. Relationship of necrosis to organ failure in severe acute pancreatitis
39. Is nasogastric suction necessary in acute pancreatitis?
40. Nasogastric suction in alcoholic pancreatitis
41. An evaluation of the efficacy of nasogastric suction treatment in alcoholic pancreatitis
42. Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis
43. The use of human serum albumin in the management of acute pancreatitis. Experimental and clinical observations
44. Enteral nutrition in acute pancreatitis
45. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: A multivariate multicentre prospective study of 116 patients
46. Comparison of the safety of early enteral vs. parenteral nutrution in mild acute pancreatitis
47. Clinical nutrition in pancreatitis
48. Parenterale Ernahrung bei Pankreatitis
49. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves severity in acute pancreatitis
50. Pharmacology of the sphincter of Oddi
51. Early ductal decompression prevents the progression of biliary pancreatitis: An experimental study in the opossum
52. Gallstone pancreatitis: A prospective randomized trial of the timing of surgery
53. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones
54. Early treatment of acute biliary pancreatitis by endoscopic papillotomy
55. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis
56. Death from acute pancreatitis: MRC Multicentre clinical trial of glucagon and aprotinin
57. Multicenter clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis
58. A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis
59. A randomised, double blind, multicenter trial of octreotide in moderate to severe acute pancreatitis
60. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis
61. Gabexate mesilate in human acute pancreatitis. German pancreatitis study group
62. The role of oxygen radicals in acute pancreatitis. Clinical and experimental results of therapy with free radical scavengers
63. Plasmapheresis: A rational treatment for fulminant acute pancreatitis
64. Plasma separation combined with CVVHF in septic and SIRS patients
65. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leucocyte proteases and their major inhibitors
66. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis
67. Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept
68. Bacterial contamination of pancreatic necrosis. A prospective clinical study
69. The use of ampicillin in acute pancreatitis
70. A prospective study to determine the efficacy of antibiotics in acute pancreatitis
71. Evaluation of prophylactic antibiotics in acute pancreatitis
72. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis
73. Early antibiotic treatment in acute necrotising pancreatitis
74. Antibiotika bei nekrotisierender Pankreatitis
75. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem
76. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis
77. The penetration of antibiotics into human pancreas
78. Human pancreatic tissue concentrations of bactericidal antibiotics
79. Excretion of azlocillin and mezlocillin by the normal pancreas and in acute pancreatitis in dogs and rats
80. Penetration of ceftazidime into human pancreas
81. Die Rolle der bakteriellen Infektion und Moglichkeiten der antibiotischen Behandlung bei der akuten Pankreatitis
82. Die Pankreasgangigkeit von Antibiotica
83. Die Pankreaspenetration von Ofloxacin - Eine Pilotstudie
84. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis
85. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study
86. CT-guided needle aspiration of pancreatic infection: Accuracy and prognostic implications
87. Early diagnosis of pancreatic infection by computed tomography-guided aspiration
88. Surgical treatment of infected necrosis
89. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis
90. Prognostic factors in sterile pancreatic necrosis
91. Indications for surgery in severe acute pancreatitis
92. Early surgical debridement of pancreatic necrosis is beneficial irrespective of infection
93. Surgical strategies in acute pancreatitis
94. Debridement and closed packing for the treatment of necrotizing pancreatitis
95. Chirurgische Therapie der schweren akuten Pankreatitis
96. Acute necrotizing pancreatitis
97. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: Techniques and results
98. Pseudocyst predisposes to infection when pancreatic necrosis is unrecognized
99. Wandel in der Therapie der schweren akuten Pankreatitis
100. Hypocalcaemia of acute pancreatitis: The effect of hypoalbuminaemia
101. Risk factors for pancreatic cellular injury after cardiopulmonary bypass
102. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat
103. Protective effect of antithrombin III in acute experimental pancreatitis in rats